References
Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674. doi:10.1056/NEJMsr070105
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 9 Regs Limited-Use, Nov 2007 Sub (1973–2005) released April 2008, based on the November 2007 submission
Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152–1161. doi:10.1093/jnci/djm059
Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(11):641–644
Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R et al (2008) Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299:1036–1045. doi:10.1001/jama.299.9.1036
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cronin, K.A., Ravdin, P.M. & Edwards, B.K. Sustained lower rates of breast cancer in the United States. Breast Cancer Res Treat 117, 223–224 (2009). https://doi.org/10.1007/s10549-008-0226-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0226-8